Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.
作者信息
Brooks P M, Bell M A, Burns H
出版信息
Br J Clin Pharmacol. 1976 Oct;3(5):945-6. doi: 10.1111/j.1365-2125.1976.tb00656.x.
Abstract
摘要
相似文献
1
Salivary antipyrine half-life: a useful measure of hepatic drug metabolism.唾液中安替比林半衰期：肝脏药物代谢的一项有用指标。
Br J Clin Pharmacol. 1976 Oct;3(5):945-6. doi: 10.1111/j.1365-2125.1976.tb00656.x.
2
Assessment of antipyrine kinetics by measurement in saliva.通过唾液测量评估安替比林动力学。
Br J Clin Pharmacol. 1976 Apr;3(2):321-5. doi: 10.1111/j.1365-2125.1976.tb00610.x.
3
Enhanced drug metabolism in cigarette smokers.吸烟者体内药物代谢增强。
Br Med J. 1976 Jul 17;2(6028):147-9. doi: 10.1136/bmj.2.6028.147.
4
Factors influencing antipyrine elimination.影响安替比林消除的因素。
Br J Clin Pharmacol. 1977 Jun;4(3):261-5. doi: 10.1111/j.1365-2125.1977.tb00710.x.
5
Elimination of antipyrine from saliva as a measure of metabolism in man.通过测定唾液中安替比林的消除情况来衡量人体新陈代谢。
Clin Pharmacol Ther. 1975 Sep;18(3):249-58. doi: 10.1002/cpt1975183249.
6
Antipyrine disposition in milk and saliva of lactating women.
Clin Pharmacol Ther. 1982 Jan;31(1):38-44. doi: 10.1038/clpt.1982.6.
7
Antipyrine kinetics in liver disease and liver transplantation.肝病及肝移植中的安替比林动力学
Clin Pharmacol Ther. 1986 Apr;39(4):372-7. doi: 10.1038/clpt.1986.57.
8
Saliva and plasma clearance of antipyrine as reflectors of liver function.安替比林的唾液和血浆清除率作为肝功能的反映指标。
Eur J Drug Metab Pharmacokinet. 1981;6(4):261-4. doi: 10.1007/BF03189523.
9
Salivary antipyrine kinetics in hepatic and renal disease and in patients on anticonvulsant therapy.
Aust N Z J Med. 1977 Aug;7(4):385-90. doi: 10.1111/j.1445-5994.1977.tb04401.x.
10
Antipyrine: radioimmunoassay in plasma and saliva following administration of a high dose and a low dose.
Clin Pharmacol Ther. 1976 Aug;20(2):219-26. doi: 10.1002/cpt1976202219.
引用本文的文献
1
Clinical implications of enzyme induction and enzyme inhibition.酶诱导和酶抑制的临床意义。
Clin Pharmacokinet. 1981 Jan-Feb;6(1):1-24. doi: 10.2165/00003088-198106010-00001.
2
Pharmacokinetics of antipyrine in epileptic patients.癫痫患者中安替比林的药代动力学
Br J Clin Pharmacol. 1986 May;21(5):511-4. doi: 10.1111/j.1365-2125.1986.tb02833.x.
3
Comparison of medigoxin and digoxin in the control of atrial fibrillation.甲基地高辛与地高辛控制心房颤动的比较。
Br J Clin Pharmacol. 1979 Jul;8(1):53-8. doi: 10.1111/j.1365-2125.1979.tb05909.x.
4
Oral absorption and secretion of drugs.药物的口服吸收与分泌
Br J Clin Pharmacol. 1977 Apr;4(2):97-100. doi: 10.1111/j.1365-2125.1977.tb00678.x.
本文引用的文献
1
Assessment of plasma glutamyl transpeptidase activity and urinary D-glucaric acid excretion as indices of enzyme induction.评估血浆谷氨酰转肽酶活性和尿中D-葡糖醛酸排泄作为酶诱导指标的情况。
Clin Sci Mol Med. 1974 Sep;47(3):279-83. doi: 10.1042/cs0470279.
2
Studies on the disposition of antipyrine, aminopyrine, and phenacetin using plasma, saliva, and urine.利用血浆、唾液和尿液对安替比林、氨基比林和非那西丁进行的处置研究。
Clin Pharmacol Ther. 1975 Sep;18(3):259-72. doi: 10.1002/cpt1975183259.
3
Relationship between digoxin concentrations in serum and saliva.
Clin Pharmacol Ther. 1975 Mar;17(3):310-2. doi: 10.1002/cpt1975173310.
Zotero 插件